Palantir vs. Salesforce: Two Visions of Enterprise AI, One Clear Winner

Vandita Jadeja

Sun, August 9, 2026 at 5:30 PM GMT+3 4 min read

Quick Read

PLTR's 93% revenue surge and 149% U.S. commercial growth contrast sharply with CRM's steadier 13% lift and a P/E of 139 versus 22.
Salesforce's Agentforce ARR hit $1.2 billion, up 205%, signaling a real product pivot beneath what looks like modest topline growth.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Salesforce didn't make the cut. Grab the names FREE today.

Palantir (NASDAQ: PLTR) and Salesforce (NYSE: CRM) both delivered fresh earnings with a striking contrast.

deepakiqlect / BY-SA 2.0

Palantir posted a 92.83% revenue surge on August 3, 2026, while Salesforce reported a steadier 13.27% lift on May 27, 2026. Both want to own the agentic AI conversation from very different starting lines.

Sovereign AI Lifts Palantir. Agentforce Anchors Salesforce.

Palantir's quarter was, in CEO Alex Karp's words, "otherworldly." U.S. commercial revenue reached $764 million, up 149% year over year, as Foundry and AIP customers scaled from pilots into production.

U.S. government revenue hit $809 million, up 90%, powered by Gotham deployments. The company closed 73 deals of at least $10 million, striking commercial cadence for a firm long viewed as a Beltway shop.

Salesforce played differently. Marc Benioff called it "an outstanding quarter", anchored by Agentforce embedded across every Customer 360 app.

Agentforce ARR reached $1.2 billion, up 205%, with customers processing 3.8 billion Agentic Work Units. Slack's Model Context Protocol crossed 1 million active users within six weeks. Modest topline growth masks a real product pivot.

Business Driver

Palantir

Salesforce

Main Growth Engine

U.S. commercial AIP deployments

Agentforce across installed base

Signature Metric

Rule of 40 at 155%

CRPO of $33.6 billion

Management Tone

Evangelical about sovereignty

Confident, capital-return focused

Hypergrowth Bet vs. Cash Return Machine

Palantir is reinvesting every dollar into a land grab. FY26 revenue guidance was raised to $8.15 to $8.158 billion, implying 82% growth, with adjusted free cash flow guided to $4.5 to $4.7 billion. The stock trades at a 139 P/E, leaving zero margin for error.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Salesforce didn't make the cut. Grab the names FREE today.

Lens

Palantir

Salesforce

Core Bet

Operational AI for sovereigns

Agentic layer on Customer 360

Capital Priority

Reinvest for hypergrowth

Buybacks and dividend

Key Vulnerability

Valuation, contract cancellations

Informatica integration, debt load

Salesforce chose a different lever. The company executed a $25 billion accelerated share repurchase, funded by debt that ballooned noncurrent liabilities to $39.3 billion. Diluted share count fell to 871 million from 970 million. FY27 revenue is guided to $45.9 to $46.2 billion. A P/E near 22 reflects mature enterprise franchise treatment.

The Next Test Is Whether Growth Compounds

For Palantir, I will watch whether U.S. commercial sustains triple-digit growth as the pipeline works through its $6.238 billion in remaining deal value. Insider activity has been net selling. Shares are up 24.09% since the earnings report, though PLTR is still off 13.16% over one year.

For Salesforce, the tell is whether Agentforce bookings convert into reported revenue acceleration in the back half of FY27. Europe growing 18% is a genuine bright spot. The stock is down 29.13% year to date.

Why I Lean Toward Salesforce

Palantir has clearly earned its AI sovereignty story. The 62% adjusted operating margin at this growth rate is rare, but I struggle to reconcile that with a triple-digit P/E and heavy stock-based compensation.

Salesforce fits better. You get an installed base measured in tens of thousands of enterprises, a genuine agentic product with $3.4 billion in combined AI and data ARR, real free cash flow, and a valuation that does not demand perfection.

I would revisit Palantir if it pulls back meaningfully or if commercial growth holds above 100% into 2027. On a risk-adjusted basis, CRM screens more favorably today.